Skip to main content
. 2020 Jul 29;61(8):44. doi: 10.1167/iovs.61.8.44

Figure 3.

Figure 3.

Butaprost increases cAMP levels. Butaprost increased scleral cAMP relative to the fellow and vehicle-injected eyes during normal ocular growth (A). FD increased scleral cAMP relative to their fellow eyes with no significant differences amongst the treated (“T”) eyes (B). Mean cAMP data presented as femtomole/milligram of the tissue (± SD). #P < 0.05, paired sample t-test, *P < 0.05; **P < 0.01; one-way ANOVA with Bonferroni correction.